Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 5 Similar Profiles
Macrophages
Medicine & Life Sciences
Nitric Oxide
Medicine & Life Sciences
Lung
Medicine & Life Sciences
Mustard Gas
Medicine & Life Sciences
Lung Injury
Medicine & Life Sciences
Ozone
Medicine & Life Sciences
Irritants
Medicine & Life Sciences
Keratinocytes
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2006 2021
Rutgers University Counteract Center Of Excellence
National Institutes of Health (NIH)
9/15/06 → 6/30/21
Project: Research project
Mustard Plant
Irritants
Research
Pharmaceutical Preparations
Drug Discovery
intellectual property
resources
research and development
research project
candidacy
Education And Training Program
National Institutes of Health (NIH)
7/1/14 → 9/21/16
Project: Research project
training program
threat
school
grant
education
Developing Drugs To Mitigate Parathion Intoxication
National Institutes of Health (NIH)
9/16/13 → 8/31/18
Project: Research project
Parathion
Paraoxon
Pharmaceutical Preparations
Organophosphates
Cytochrome P-450 Enzyme System
Umdnj/Rutgers University Counteract Research Center Of Excellence
National Institutes of Health (NIH)
9/15/06 → 9/21/16
Project: Research project
Irritants
Research
Pharmaceutical Preparations
Pharmaceutical Chemistry
Pharmacology
Research Output 1976 2019
Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis
Szilagyi, J. T., Composto-Wahler, G. M., Joseph, L. B., Wang, B., Rosen, T., Laskin, J. & Aleksunes, L., Mar 1 2019, In : Pharmacological Research. 141, p. 331-342 12 p.Research output: Contribution to journal › Article
Cannabinoid Receptor CB2
Trophoblasts
Down-Regulation
Cyclic AMP Response Element-Binding Protein
Messenger RNA
Sarcoid-Like Granulomatous Disease: Pathologic Case Series in World Trade Center Dust Exposed Rescue and Recovery Workers
Sunil, V. R., Radbel, J., Hussain, S., Vayas, K. N., Cervelli, J., Deen, M., Kipen, H., Udasin, I., Laumbach, R., Sunderram, J., Laskin, J. & Laskin, D., Mar 6 2019, In : International journal of environmental research and public health. 16, 5Research output: Contribution to journal › Article
Open Access
Dust
Lymph Nodes
Histones
Lung
Keratin-17
Synthetically modified methoxsalen for enhanced cytotoxicity in light and dark reactions
Guillon, C. D., Jan, Y. H., Foster, N., Ressner, J., Heck, D. E., Laskin, J. & Heindel, N. D., Feb 15 2019, In : Bioorganic and Medicinal Chemistry Letters. 29, 4, p. 619-622 4 p.Research output: Contribution to journal › Article
Methoxsalen
Cytotoxicity
Light
Keratinocytes
Skin Diseases
Expression of cytokines and chemokines in mouse skin treated with sulfur mustard
Chang, Y. C., Soriano, M., Hahn, R. A., Casillas, R. P., Gordon, M., Laskin, J. & Gerecke, D., Sep 15 2018, In : Toxicology and applied pharmacology. 355, p. 52-59 8 p.Research output: Contribution to journal › Article
Mustard Gas
Chemokines
Cytokines
Skin
Macrophages
1
Citation
(Scopus)
Identification of a Pyranocoumarin Photosensitizer that is a Potent Inhibitor of Keratinocyte Growth
Laskin, J., Jan, Y. H., Jetter, M. M., Guillon, C. D., Mariano, T. M., Heck, D. E. & Heindel, N. D., May 1 2018, In : Photochemistry and photobiology. 94, 3, p. 577-582 6 p.Research output: Contribution to journal › Article
Pyranocoumarins
Growth Inhibitors
Photosensitizing Agents
Keratinocytes
Pyrans
Press/Media
New Jersey Health Foundation Awards Excellence in Teaching, Research
Cheryl Dreyfus, Jeffrey Laskin, Ronald Ellis, Jane Ziegler & Debra Laskin
6/5/17 → 6/6/17
70 items of media coverage
Rutgers, The State University, Rowan University
Press/Media: Press / Media
New Jersey Health Foundation Awards Excellence in Teaching Research
Ronald Ellis, Debra Laskin, Cheryl Dreyfus, Jeffrey Laskin & Jane Ziegler
6/5/17
1 item of media coverage
Rutgers, The State University, Rowan University
Press/Media: Press / Media
$19 million to develop drugs to treat victims of chemical weapons attacks
12/8/16
1 item of media coverage
Press/Media: Press / Media
Rutgers Receives $19 Million to Develop Drugs to Treat Chemical Weapons Attacks
Marion Gordon, Debra Laskin, Donald Gerecke, Jeffrey Laskin & Patrick Sinko
12/1/16
4 items of media coverage
Press/Media: Press / Media
US Patent Issued to Rutgers, The State University of New Jersey, LEHIGH UNIVERSITY on Aug. 23 for "Vanilloid fatty hydroxamates as therapeutic anti-inflammatory pharmaceuticals" (American, Indian Inventors)
Marion Gordon & Jeffrey Laskin
8/23/16
1 item of media coverage
Press/Media: Press / Media